These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9355572)

  • 21. Genetic counseling and testing for breast cancer risk in African Americans.
    Halbert CH
    LDI Issue Brief; 2006 Sep; 12(1):1-4. PubMed ID: 17302016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guidelines for genetic risk assessment of hereditary breast and ovarian cancer: early disagreements and low utilization.
    Levy DE; Garber JE; Shields AE
    J Gen Intern Med; 2009 Jul; 24(7):822-8. PubMed ID: 19455369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer.
    Lipkus IM; Iden D; Terrenoire J; Feaganes JR
    Cancer Epidemiol Biomarkers Prev; 1999 Jun; 8(6):533-9. PubMed ID: 10385144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Community attitudes towards a Jewish community BRCA1/2 testing program.
    Cousens N; Kaur R; Meiser B; Andrews L
    Fam Cancer; 2017 Jan; 16(1):17-28. PubMed ID: 27480161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of receiving genetic test results on general and cancer-specific psychologic distress among members of an African-American kindred with a BRCA1 mutation.
    Kinney AY; Bloor LE; Mandal D; Simonsen SE; Baty BJ; Holubkov R; Seggar K; Neuhausen S; Smith K
    Cancer; 2005 Dec; 104(11):2508-16. PubMed ID: 16222692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BRCA1/2 test results impact risk management attitudes, intentions, and uptake.
    O'Neill SC; Valdimarsdottir HB; Demarco TA; Peshkin BN; Graves KD; Brown K; Hurley KE; Isaacs C; Hecker S; Schwartz MD
    Breast Cancer Res Treat; 2010 Dec; 124(3):755-64. PubMed ID: 20383578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hereditary breast and ovarian cancer syndrome : the impact of race on uptake of genetic counseling and testing.
    Simon MS; Petrucelli N
    Methods Mol Biol; 2009; 471():487-500. PubMed ID: 19109796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychological distress in women seeking genetic counseling for breast-ovarian cancer risk: the contributions of personality and appraisal.
    Audrain J; Schwartz MD; Lerman C; Hughes C; Peshkin BN; Biesecker B
    Ann Behav Med; 1997; 19(4):370-7. PubMed ID: 9706364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A population-based study of Ashkenazi Jewish women's attitudes toward genetic discrimination and BRCA1/2 testing.
    Lehmann LS; Weeks JC; Klar N; Garber JE
    Genet Med; 2002; 4(5):346-52. PubMed ID: 12394347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knowledge about genetic risk for breast cancer and perceptions of genetic testing in a sociodemographically diverse sample.
    Donovan KA; Tucker DC
    J Behav Med; 2000 Feb; 23(1):15-36. PubMed ID: 10749009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attitudes about breast cancer and mammography: racial, income, and educational differences.
    Miller AM; Champion VL
    Women Health; 1997; 26(1):41-63. PubMed ID: 9311099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
    Lerman C; Biesecker B; Benkendorf JL; Kerner J; Gomez-Caminero A; Hughes C; Reed MM
    J Natl Cancer Inst; 1997 Jan; 89(2):148-57. PubMed ID: 8998184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
    Lerman C; Narod S; Schulman K; Hughes C; Gomez-Caminero A; Bonney G; Gold K; Trock B; Main D; Lynch J; Fulmore C; Snyder C; Lemon SJ; Conway T; Tonin P; Lenoir G; Lynch H
    JAMA; 1996 Jun; 275(24):1885-92. PubMed ID: 8648868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2.
    Bluman LG; Rimer BK; Berry DA; Borstelmann N; Iglehart JD; Regan K; Schildkraut J; Winer EP
    J Clin Oncol; 1999 Mar; 17(3):1040-6. PubMed ID: 10071299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience.
    Bakos AD; Hutson SP; Loud JT; Peters JA; Giusti RM; Greene MH
    Health Expect; 2008 Sep; 11(3):220-31. PubMed ID: 18816319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attitudes toward genetic testing in patients with colorectal cancer.
    Kinney AY; Choi YA; DeVellis B; Millikan R; Kobetz E; Sandler RS
    Cancer Pract; 2000; 8(4):178-86. PubMed ID: 11898257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in Positive BRCA Test Results Among Older Women in the United States, 2008-2018.
    Guo F; Scholl M; Fuchs EL; Wong R; Kuo YF; Berenson AB
    JAMA Netw Open; 2020 Nov; 3(11):e2024358. PubMed ID: 33151316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences between African Americans and Whites in their attitudes toward genetic testing for Alzheimer's disease.
    Hipps YG; Roberts JS; Farrer LA; Green RC
    Genet Test; 2003; 7(1):39-44. PubMed ID: 12820701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer genetics knowledge and beliefs and receipt of results in Ashkenazi Jewish individuals receiving counseling for BRCA1/2 mutations.
    Kelly K; Leventhal H; Marvin M; Toppmeyer D; Baran J; Schwalb M
    Cancer Control; 2004; 11(4):236-44. PubMed ID: 15284715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study.
    Høberg-Vetti H; Bjorvatn C; Fiane BE; Aas T; Woie K; Espelid H; Rusken T; Eikesdal HP; Listøl W; Haavind MT; Knappskog PM; Haukanes BI; Steen VM; Hoogerbrugge N
    Eur J Hum Genet; 2016 Jun; 24(6):881-8. PubMed ID: 26350514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.